DAFTAR PUSTAKA

Arima, Aria, C. 2006. Paralisis saraf kranial multipel pada karsinoma nasofaring.

Comolli P, Pedrazolli, Maccario, et al. 2005. Cell therapy of stage IV nasopharyngeal

carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J

Clin Oncol. 10;23(35):8942-9.

Clark, E.J., Connor, S., Taylor, M.A., Madhavan, K.K., Garden, O.J., Parks, R.W. 2007.

Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal

adenocarcinoma. HPB (Oxford). 9:456-460.

De Palma, M., Coussens, L.M. 2008. Immune cells and inflammatory mediators as regulators

of tumor angiogenesis. In: Figg WD, Folkman J, editors. Angiogenesis: an integrative

approach from science to medicine. New York: Springer. 225-38.

Finn, O.J. 2012. Immuno-oncology: understanding the function and the dysfunction of the

immune system in cancer. Annals of Oncology. 23(8).

Goldenberg, G.J., Brandes, L.J. 1976. In vivo and in vitro studies of immunotherapy of

nasopharyngeal carcinoma with transfer factor. 720-723.

Greenle, R.T., et al. CA Cancer J Clin. 2001:51;15-36.

Henle, G., Henle, W. 1976. Epstein-Barr-Virus-spesific IgA serum antibodies as an

outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 17:1-17.

Hirayama, T. 1978. Descriptive and analytical epidemiology of nasopharyngeal cancer. In de-

The G, Ito Y (eds): Nasopharyngeal Carcinoma: Etiology and Control, bo. 20. Lyon,

France, International Agency for Research on Cance, pp 840-41.

Ho, J.H.C. 1971. Genetic and environmental factors in nasopharyngeal carcinoma. ln:

Nakahara, W, Nishioka, N., Hirayama, 'I & Ho, Y., eds, Recent Advances in Tumor

Virology and lmmunology, Baltimore, MD, University Park Press, pp. 275-295.

Huang, D.P., Ho, H.C., Henle, W., et al. 1978. Presence of EBNA in nasopharyngeal

carcinoma adn control patient tissues related to EBV serology. Int J Cancer. 22:226-

274.

Kundu, J.K., Surh, Y.J.,2008. Inflammation: Gearing the journey to cancer. Mutation

Research. 659:15-30.

Indrasari, S.R. 2009. Penatalaksanaan terkini karsinoma nasofarings. Kumpulan Makalah

Simposium Tumor Kepala dan Leher. Yogyakarta.

Jiang, Rou, Cai, Xiu-Yu, Yang, Zhong-Hang, et al., 2015. Elevated peripheral blood

lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with

metastatic nasopharyngeal carcinoma. Chin J Cancer. 34: 23.

Lu ,S, Chang, H, Sun, X., et al., 2016. Long-Term Outcomes of Nasopharyngeal Carcinoma

in 148 Children and Adolescents. Baltimore. (17):e3445.

McMillan, D.C. 2009. Systemic inflammation, nutritional status and survival in patients with

cancer. Curr Opin Nutr Metab Care. 12:223-6.

Nasir, N. 2009. Karsinoma nasofaring. Kedokteran Islam.

Parkin, D.M., Bray, F., Ferlay, J., Pisani, P. 2002. Global cancer statistics. CA Cancer J Clin.

55:74-108.

Pezzuto, F, Buonaquro, L, Caponicro, F, et al., 2015. Update on Head and Neck Cancer:

Current Knowledge on Epidemiology, Risk Factors, Molecular Features and Novel

Therapies. Oncology. 89(3):125-36.

Roezin, A., Anida, S. 2007. Karsinoma nasofaring. Dalam: Buku Ajar Telinga Hidung,

Tenggorok Kepala Dan Leher. Edisi 6, Jakarta: Fakultas Kedokteran Universitas

Indonesia, 146-150.

Schmidt, H., Bastholt, L., Geersten, P., et al. Elevated neutrophil and monocyte counts in

peripheral blood are associated with poor survival in patients with metastatic

melanoma: a prognostic model. Br J Cancer. 93:273-278.

Wided, BA, Hamouda, B, Hamadi, H, et al., 2015. Nasopharyngeal carcinoma incidence in

North Tunisia: negative trends in adults but not adolescents, 1994-2006. Asian Pac J

Cancer. 16(7):2653-7.

Yu, M.C., Yuan, J.M. 2012. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol.

12:421-429.